Dihydromyricetin Improves Physical Performance under Simulated High Altitude
- 1 November 2014
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine & Science in Sports & Exercise
- Vol. 46 (11), 2077-2084
- https://doi.org/10.1249/mss.0000000000000336
Abstract
Purpose Dihydromyricetin (DHM) is the major bioactive constituent of rattan tea. Our aim was to investigate the possible mechanism and the effect of DHM in counteracting hypobaric hypoxia (HH)-induced exercise intolerance. Methods Male Sprague–Dawley rats were pretreated with three doses of DHM (50, 75, and 100 mg·kg−1) for 7 d and subjected to simulated high-altitude conditions (5000 m with 10.9% oxygen). Physical performance was assessed with the run-to-fatigue model. Mitochondrial morphology in the gastrocnemius muscle was observed by transmission electron microscopy. Protein expression was detected by western blotting. The activity of mitochondrial electron transport chain was analyzed by enzyme-linked immunosorbent assay. Results DHM administration prolonged the run-to-fatigue time in a dose-dependent manner compared with the control (22.9 ± 2.2, 46.1 ± 4.4, 61.3 ± 3.1 vs 18.4 ± 1.7 min, which represented 50, 75, 100 mg·kg−1, and the control groups, respectively). DHM also reduced serum blood urea nitrogen, lactate dehydrogenase, and creatine kinase activity levels. HH-induced mitochondrial injuries, including morphological changes, reduction in mitochondrial density and mitochondrial DNA content, and decrease in respiratory chain complex (I, II, IV, and V) activities were effectively attenuated by DHM. Protein expression of mitochondrial biogenesis markers, including peroxisome proliferator-activated receptor-γcoactivator 1α, sirtuin 1, nuclear respiratory factor 1, mitochondrial transcription factor A, AMP-activated protein kinase, and AMP-activated protein kinase phosphorylation, was significantly downregulated in HH, whereas DHM pretreatment significantly restored expression levels. DHM also modulated mitochondrial dynamics of fusion and fission by increasing mitofusins 1 and 2, while decreasing fission-related, dynamin-related protein 1 and mitochondrial fission 1. Conclusions DHM improves physical performance under simulated high-altitude conditions via protecting mitochondrial biogenesis and modulating mitochondrial dynamics in skeletal muscle cells.Keywords
This publication has 30 references indexed in Scilit:
- Adaptability to hypobaric hypoxia is facilitated through mitochondrial bioenergetics: an in vivo studyBritish Journal of Pharmacology, 2013
- Acute Mountain Sickness ProphylaxisOptometry and Vision Science, 2013
- The Effect of High-Altitude on Human Skeletal Muscle Energetics: 31P-MRS Results from the Caudwell Xtreme Everest ExpeditionPLOS ONE, 2010
- Exercise: it's the real thing!Nutrition Reviews, 2009
- Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers training-induced adaptations in endurance performanceThe American Journal of Clinical Nutrition, 2008
- Selective activation of AMPK‐PGC‐1α or PKB‐TSC2‐mTOR signaling can explain specific adaptive responses to endurance or resistance training‐like electrical muscle stimulationThe FASEB Journal, 2005
- Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscleThe FASEB Journal, 2004
- Limiting factors to oxygen transport on Mount Everest 30 years after: a critique of Paolo Cerretelli’s contribution to the study of altitude physiologyEuropean Journal of Applied Physiology, 2003
- Determinants of maximal oxygen uptake in severe acute hypoxiaAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2003
- The Role of Dynamin-Related Protein 1, a Mediator of Mitochondrial Fission, in ApoptosisDevelopmental Cell, 2001